MarketBeat on MSN
Edwards Lifesciences Q2 earnings call highlights
A Closer Look at Healthcare Sector Earnings: AZN vs. EW vs. ZBH Edwards Lifesciences (NYSE:EW) reported ...
Investor's Business Daily on MSN
Edwards, the 'cleanest large-cap medtech story,' launches on second-quarter beat
Edwards Lifesciences stock launched higher Friday after the medtech company beat Wall Street's top- and bottom-line ...
Edwards Lifesciences (NYSE: EW) today reported financial results for the quarter ended June 30, 2026. Highlights. Q2 sales grew 13.
Edwards Lifesciences Corporation EW recently gained CE Mark for its PASCAL Precision transcatheter valve repair system used to treat mitral and tricuspid regurgitation. The PASCAL Precision system is ...
An upcoming Medicare coverage decision for transcatheter aortic valve replacement devices and study readout for patients with ...
Detailed price information for Edwards Lifesciences Corp (EW-N) from The Globe and Mail including charting and trades.
SAN FRANCISCO, Oct. 26, 2023 /PRNewswire/ -- Edwards Lifesciences Corporation (NYSE: EW) announced one-year results from CLASP IID, the first randomized controlled trial that directly compares two ...
IRVINE, Calif., Oct. 19, 2023 /PRNewswire/ -- Edwards Lifesciences Corporation (NYSE: EW) today announced the company's EVOQUE tricuspid valve replacement system received CE Mark for the transcatheter ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results